Oesophageal Cancer Trial, Recruiting NCT07561840 Sponsor: Kansai Medical University Condition: Oesophageal Cancer
Back to Oesophageal Cancer

Oesophageal Cancer Trial, Recruiting

NCT07561840
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who have been diagnosed with cancer of the oesophagus (food pipe) or stomach
  • People who have had surgery aimed at fully removing the cancer
  • People who are between 4 and 8 weeks after their surgery at the time of joining
  • People who are able to read and sign a consent form agreeing to take part

Who may not be able to join:

  • People who have difficulty communicating
  • People whose overall health is considered too poor (confirm with trial site)
  • People who have also had surgery to remove the voice box and/or throat (laryngopharyngectomy)
  • People who are not considered suitable for the assessments or exercise program involved in the study (confirm with trial site)
  • People whose treating doctor determines they are not appropriate for the study for any other reason

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Takuya Fukushima, Kansai Medical University

Phone: +81-72-856-2115

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Kansai Medical University
Registry
ClinicalTrials.gov
Start date
15 May 2026
Est. completion
1 November 2029

Where this trial is recruiting

🇯🇵 Japan

Primary endpoints

Peak oxygen uptake (VO₂peak)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov